CN Stock MarketDetailed Quotes

603676 Xizang Weixinkang Pharmaceutical

Watchlist
  • 9.41
  • -0.31-3.19%
Market Closed Jan 10 15:00 CST
4.09BMarket Cap16.57P/E (TTM)

Xizang Weixinkang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-28.58%244.36M
-11.55%358.19M
-6.54%353.29M
-48.12%269.43M
106.98%342.16M
123.00%404.98M
88.72%378.03M
113.03%519.32M
-29.40%165.31M
18.71%181.6M
Transactional financial assets
64.58%815M
88.28%687.61M
38.37%650.32M
117.88%625.32M
-19.66%495.21M
-32.72%365.21M
-9.42%470M
-38.65%287M
50.45%616.4M
16.00%542.8M
Notes receivable and accounts receivable
-27.95%189.33M
-31.38%189.53M
-14.44%202.32M
-18.42%178.85M
8.84%262.76M
17.28%276.22M
2.86%236.47M
14.00%219.23M
8.99%241.41M
-13.55%235.52M
-Accounts receivable
-27.95%189.33M
-31.38%189.53M
-14.44%202.32M
-18.42%178.85M
8.84%262.76M
17.28%276.22M
2.86%236.47M
14.00%219.23M
8.99%241.41M
-13.55%235.52M
Other receivables (including interest and dividends)
-25.45%2.19M
42.34%4.17M
-3.52%2.35M
2.75%2.2M
39.20%2.94M
54.23%2.93M
56.19%2.44M
75.47%2.14M
46.84%2.11M
31.71%1.9M
-Other receivable
----
42.34%4.17M
----
----
----
54.23%2.93M
----
75.47%2.14M
----
31.71%1.9M
Advance payment
4.64%72.98M
24.59%82.64M
15.87%83.21M
9.02%78.16M
1.12%69.75M
-1.93%66.33M
-8.98%71.81M
-8.09%71.7M
-30.85%68.98M
-15.40%67.63M
Inventories
2.38%36.05M
-1.59%34.19M
-8.69%33.3M
17.83%38.34M
34.83%35.21M
35.61%34.74M
50.54%36.47M
43.50%32.54M
14.25%26.11M
21.21%25.62M
Receivable financing
-31.21%362.66K
-7.94%906.66K
12.32%1.57M
-74.73%915.56K
-5.85%527.24K
86.22%984.9K
-69.69%1.4M
340.15%3.62M
-81.58%560.02K
-79.54%528.9K
Other current assets
28.01%6.54M
49.89%5.35M
47.84%5.15M
95.33%6.68M
77.39%5.11M
44.83%3.57M
57.23%3.49M
32.85%3.42M
-19.34%2.88M
40.22%2.47M
Total current assets
12.62%1.37B
17.98%1.36B
10.95%1.33B
5.35%1.2B
8.00%1.21B
9.16%1.15B
13.15%1.2B
12.86%1.14B
12.83%1.12B
5.78%1.06B
Non Current assets
Other equity investment
----
----
----
----
1.38%75.36M
5.87%72.29M
9.00%71.36M
14.16%71.33M
32.99%74.33M
21.65%68.28M
Other non-current financial assets
--72.26M
--76.98M
--74.92M
--75.88M
----
----
----
----
----
----
Investment real estate
--3.24M
--3.31M
----
----
----
----
----
----
----
----
Fixed assets
----
4.39%321.33M
----
----
----
-0.50%307.83M
----
-2.60%308.03M
----
8.48%309.38M
Constru in process
----
-16.64%17.47M
----
----
----
--20.95M
----
--17.11M
----
----
Intangible assets
55.46%32.71M
42.86%31.41M
46.16%33.38M
45.07%35.39M
4.41%21.04M
22.93%21.98M
88.95%22.84M
90.20%24.4M
22.71%20.15M
5.37%17.88M
Development expenditure
-48.48%19.93M
-39.64%23.07M
-39.88%22.94M
-40.83%22.52M
-7.19%38.69M
-44.06%38.22M
-47.14%38.15M
-44.62%38.06M
-32.89%41.68M
18.23%68.33M
Long deferred expense
5.82%3.48M
31.03%3.93M
29.31%4.39M
10.82%3.84M
-18.22%3.29M
-33.76%3M
-24.59%3.4M
-25.19%3.47M
-9.88%4.03M
-7.15%4.52M
Deferred tax assets
4.81%46.39M
36.81%52.27M
70.21%51.49M
86.27%56.21M
132.70%44.26M
180.81%38.2M
154.97%30.25M
209.52%30.18M
184.88%19.02M
77.30%13.61M
Usufruct assets
5.98%11.32M
-2.65%10.85M
-36.86%7.76M
8.26%9.31M
48.28%10.68M
70.39%11.14M
68.00%12.3M
8.74%8.6M
-10.89%7.2M
22.73%6.54M
Other non current assets
-39.77%15.58M
-17.50%25.86M
-39.63%16.89M
-13.27%21.93M
39.49%25.87M
32.30%31.35M
268.09%27.97M
556.84%25.29M
255.09%18.55M
72.95%23.7M
Total non current assets
1.51%566.7M
3.95%566.48M
5.61%562.73M
9.60%576.99M
11.29%558.28M
6.39%544.97M
7.91%532.82M
8.23%526.45M
4.74%501.64M
8.75%512.23M
Total assets
9.12%1.93B
13.48%1.93B
9.31%1.89B
6.69%1.78B
9.02%1.77B
8.26%1.7B
11.49%1.73B
11.36%1.67B
10.20%1.63B
6.73%1.57B
Liabilities
Current liabilities
Notes payable and accounts payable
12.35%283.91M
11.78%285.68M
6.17%272.39M
-3.26%229.16M
-6.08%252.69M
-5.75%255.58M
-3.54%256.57M
-3.17%236.87M
-3.53%269.04M
-16.57%271.18M
-Accounts payable
12.35%283.91M
11.78%285.68M
6.17%272.39M
-3.26%229.16M
-6.08%252.69M
-5.75%255.58M
-3.54%256.57M
-3.17%236.87M
-3.53%269.04M
-16.57%271.18M
Contract liabilities
27.35%3.88M
-19.32%3.59M
-37.26%3.62M
-35.98%4.19M
-18.44%3.04M
-7.84%4.45M
4.54%5.76M
-15.60%6.54M
-34.83%3.73M
7.44%4.83M
Advance receipts
--39.76K
--99.39K
--159.02K
--218.65K
----
----
----
----
----
----
Salaries payable
-25.38%9.39M
-22.30%10.14M
11.04%13.13M
22.51%37.23M
73.68%12.58M
61.25%13.06M
49.67%11.83M
34.80%30.39M
32.90%7.25M
29.70%8.1M
Taxs payable
-16.09%14.7M
-41.97%11.36M
-2.74%17.53M
-47.24%10.8M
-25.00%17.52M
4.43%19.58M
16.18%18.02M
59.84%20.47M
60.41%23.36M
38.83%18.75M
Other payable (including interest and dividends)
-12.53%90.75M
59.97%167.21M
-5.68%107.76M
-4.90%108.79M
-1.37%103.76M
-20.45%104.53M
-11.55%114.25M
-10.71%114.39M
-12.87%105.2M
17.24%131.4M
-Dividend payable
135.53%24.48M
819.62%95.58M
250.02%3.39M
456.31%5.39M
868.17%10.39M
430.97%10.39M
--969.52K
--969.52K
--1.07M
--1.96M
-Other payable
----
-23.90%71.63M
----
----
----
-27.28%94.13M
----
-11.47%113.42M
----
15.50%129.44M
Non current liabilities due within one year
-7.74%3.54M
-0.23%3.78M
-11.21%3.27M
67.01%3.86M
314.24%3.84M
168.35%3.79M
116.67%3.68M
-6.21%2.31M
--926.42K
--1.41M
Other current liabilities
28.97%504.02K
-17.55%466.97K
-35.55%470.21K
-33.85%544.17K
-18.63%390.81K
-7.99%566.39K
4.67%729.55K
-13.00%822.62K
-28.46%480.3K
31.05%615.6K
Total current liabilities
3.27%406.72M
20.12%482.34M
1.82%418.33M
-4.13%394.79M
-3.94%393.83M
-7.96%401.55M
-3.66%410.85M
-1.78%411.8M
-3.77%409.99M
-5.53%436.28M
Current liabilities
Long term salaries pay
32.41%30.64M
32.41%30.64M
32.41%30.64M
32.41%30.64M
--23.14M
--23.14M
--23.14M
--23.14M
----
----
Deferred tax liabilities
108.91%3.16M
110.61%3.38M
91.05%3.31M
196.40%3.46M
--1.51M
--1.6M
--1.73M
--1.17M
----
----
Long term deferred income
-27.49%3.04M
-28.02%3.26M
-28.25%3.51M
-26.93%3.84M
-25.39%4.19M
-24.05%4.54M
-22.74%4.89M
-21.57%5.25M
-20.52%5.61M
-19.56%5.97M
Lease liabilities
52.97%7.68M
21.83%6.57M
-46.72%3.17M
9.75%3.82M
54.05%5.02M
148.00%5.4M
171.04%5.95M
48.17%3.48M
-32.46%3.26M
-15.29%2.18M
Total non current liabilities
31.47%44.52M
26.47%43.85M
13.76%40.63M
26.38%41.76M
281.61%33.86M
325.55%34.67M
318.68%35.72M
265.20%33.04M
-25.37%8.87M
-18.47%8.15M
Total liabilities
5.51%451.24M
20.62%526.2M
2.78%458.96M
-1.86%436.55M
2.11%427.69M
-1.85%436.23M
2.66%446.57M
3.86%444.84M
-4.36%418.86M
-5.80%444.43M
Shareholders equity
Paid-in capital
0.00%435.16M
0.00%435.16M
0.00%435.16M
0.00%435.16M
-0.02%435.16M
-0.02%435.16M
-0.17%435.16M
-0.17%435.16M
0.18%435.23M
2.89%435.23M
Capital reserve funds
0.14%347.64M
0.25%347.64M
0.76%347.15M
1.70%347.15M
2.62%347.15M
4.17%346.77M
5.12%344.53M
7.13%341.35M
11.48%338.29M
28.13%332.87M
Surplus reserve funds
27.98%77.97M
27.98%77.97M
27.98%77.97M
27.98%77.97M
55.12%60.92M
55.12%60.92M
55.12%60.92M
55.12%60.92M
25.06%39.28M
25.06%39.28M
Retained profit
23.67%620.9M
27.16%541.09M
31.39%596.57M
27.68%501.66M
29.21%502.06M
24.96%425.53M
31.18%454.04M
27.88%392.9M
28.86%388.57M
24.96%340.55M
Less:Treasury stock
----
----
-5.98%22.37M
-5.98%22.37M
-16.78%22.37M
-53.44%22.37M
-54.99%23.8M
-54.99%23.8M
-42.00%26.89M
--48.05M
Other composite income
-97.21%594.07K
-94.34%1M
-94.79%808.07K
-94.45%779.4K
-33.47%21.32M
-31.90%17.71M
-33.18%15.5M
-26.32%14.05M
156.85%32.05M
104.46%26M
Shareholders equity without minority interests
10.27%1.48B
11.01%1.4B
11.58%1.44B
9.81%1.34B
11.41%1.34B
12.24%1.26B
14.92%1.29B
14.37%1.22B
16.35%1.21B
12.65%1.13B
Total shareholder equity
10.27%1.48B
11.01%1.4B
11.58%1.44B
9.81%1.34B
11.41%1.34B
12.24%1.26B
14.92%1.29B
14.37%1.22B
16.35%1.21B
12.65%1.13B
Total liabilityies and equity
9.12%1.93B
13.48%1.93B
9.31%1.89B
6.69%1.78B
9.02%1.77B
8.26%1.7B
11.49%1.73B
11.36%1.67B
10.20%1.63B
6.73%1.57B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -28.58%244.36M-11.55%358.19M-6.54%353.29M-48.12%269.43M106.98%342.16M123.00%404.98M88.72%378.03M113.03%519.32M-29.40%165.31M18.71%181.6M
Transactional financial assets 64.58%815M88.28%687.61M38.37%650.32M117.88%625.32M-19.66%495.21M-32.72%365.21M-9.42%470M-38.65%287M50.45%616.4M16.00%542.8M
Notes receivable and accounts receivable -27.95%189.33M-31.38%189.53M-14.44%202.32M-18.42%178.85M8.84%262.76M17.28%276.22M2.86%236.47M14.00%219.23M8.99%241.41M-13.55%235.52M
-Accounts receivable -27.95%189.33M-31.38%189.53M-14.44%202.32M-18.42%178.85M8.84%262.76M17.28%276.22M2.86%236.47M14.00%219.23M8.99%241.41M-13.55%235.52M
Other receivables (including interest and dividends) -25.45%2.19M42.34%4.17M-3.52%2.35M2.75%2.2M39.20%2.94M54.23%2.93M56.19%2.44M75.47%2.14M46.84%2.11M31.71%1.9M
-Other receivable ----42.34%4.17M------------54.23%2.93M----75.47%2.14M----31.71%1.9M
Advance payment 4.64%72.98M24.59%82.64M15.87%83.21M9.02%78.16M1.12%69.75M-1.93%66.33M-8.98%71.81M-8.09%71.7M-30.85%68.98M-15.40%67.63M
Inventories 2.38%36.05M-1.59%34.19M-8.69%33.3M17.83%38.34M34.83%35.21M35.61%34.74M50.54%36.47M43.50%32.54M14.25%26.11M21.21%25.62M
Receivable financing -31.21%362.66K-7.94%906.66K12.32%1.57M-74.73%915.56K-5.85%527.24K86.22%984.9K-69.69%1.4M340.15%3.62M-81.58%560.02K-79.54%528.9K
Other current assets 28.01%6.54M49.89%5.35M47.84%5.15M95.33%6.68M77.39%5.11M44.83%3.57M57.23%3.49M32.85%3.42M-19.34%2.88M40.22%2.47M
Total current assets 12.62%1.37B17.98%1.36B10.95%1.33B5.35%1.2B8.00%1.21B9.16%1.15B13.15%1.2B12.86%1.14B12.83%1.12B5.78%1.06B
Non Current assets
Other equity investment ----------------1.38%75.36M5.87%72.29M9.00%71.36M14.16%71.33M32.99%74.33M21.65%68.28M
Other non-current financial assets --72.26M--76.98M--74.92M--75.88M------------------------
Investment real estate --3.24M--3.31M--------------------------------
Fixed assets ----4.39%321.33M-------------0.50%307.83M-----2.60%308.03M----8.48%309.38M
Constru in process -----16.64%17.47M--------------20.95M------17.11M--------
Intangible assets 55.46%32.71M42.86%31.41M46.16%33.38M45.07%35.39M4.41%21.04M22.93%21.98M88.95%22.84M90.20%24.4M22.71%20.15M5.37%17.88M
Development expenditure -48.48%19.93M-39.64%23.07M-39.88%22.94M-40.83%22.52M-7.19%38.69M-44.06%38.22M-47.14%38.15M-44.62%38.06M-32.89%41.68M18.23%68.33M
Long deferred expense 5.82%3.48M31.03%3.93M29.31%4.39M10.82%3.84M-18.22%3.29M-33.76%3M-24.59%3.4M-25.19%3.47M-9.88%4.03M-7.15%4.52M
Deferred tax assets 4.81%46.39M36.81%52.27M70.21%51.49M86.27%56.21M132.70%44.26M180.81%38.2M154.97%30.25M209.52%30.18M184.88%19.02M77.30%13.61M
Usufruct assets 5.98%11.32M-2.65%10.85M-36.86%7.76M8.26%9.31M48.28%10.68M70.39%11.14M68.00%12.3M8.74%8.6M-10.89%7.2M22.73%6.54M
Other non current assets -39.77%15.58M-17.50%25.86M-39.63%16.89M-13.27%21.93M39.49%25.87M32.30%31.35M268.09%27.97M556.84%25.29M255.09%18.55M72.95%23.7M
Total non current assets 1.51%566.7M3.95%566.48M5.61%562.73M9.60%576.99M11.29%558.28M6.39%544.97M7.91%532.82M8.23%526.45M4.74%501.64M8.75%512.23M
Total assets 9.12%1.93B13.48%1.93B9.31%1.89B6.69%1.78B9.02%1.77B8.26%1.7B11.49%1.73B11.36%1.67B10.20%1.63B6.73%1.57B
Liabilities
Current liabilities
Notes payable and accounts payable 12.35%283.91M11.78%285.68M6.17%272.39M-3.26%229.16M-6.08%252.69M-5.75%255.58M-3.54%256.57M-3.17%236.87M-3.53%269.04M-16.57%271.18M
-Accounts payable 12.35%283.91M11.78%285.68M6.17%272.39M-3.26%229.16M-6.08%252.69M-5.75%255.58M-3.54%256.57M-3.17%236.87M-3.53%269.04M-16.57%271.18M
Contract liabilities 27.35%3.88M-19.32%3.59M-37.26%3.62M-35.98%4.19M-18.44%3.04M-7.84%4.45M4.54%5.76M-15.60%6.54M-34.83%3.73M7.44%4.83M
Advance receipts --39.76K--99.39K--159.02K--218.65K------------------------
Salaries payable -25.38%9.39M-22.30%10.14M11.04%13.13M22.51%37.23M73.68%12.58M61.25%13.06M49.67%11.83M34.80%30.39M32.90%7.25M29.70%8.1M
Taxs payable -16.09%14.7M-41.97%11.36M-2.74%17.53M-47.24%10.8M-25.00%17.52M4.43%19.58M16.18%18.02M59.84%20.47M60.41%23.36M38.83%18.75M
Other payable (including interest and dividends) -12.53%90.75M59.97%167.21M-5.68%107.76M-4.90%108.79M-1.37%103.76M-20.45%104.53M-11.55%114.25M-10.71%114.39M-12.87%105.2M17.24%131.4M
-Dividend payable 135.53%24.48M819.62%95.58M250.02%3.39M456.31%5.39M868.17%10.39M430.97%10.39M--969.52K--969.52K--1.07M--1.96M
-Other payable -----23.90%71.63M-------------27.28%94.13M-----11.47%113.42M----15.50%129.44M
Non current liabilities due within one year -7.74%3.54M-0.23%3.78M-11.21%3.27M67.01%3.86M314.24%3.84M168.35%3.79M116.67%3.68M-6.21%2.31M--926.42K--1.41M
Other current liabilities 28.97%504.02K-17.55%466.97K-35.55%470.21K-33.85%544.17K-18.63%390.81K-7.99%566.39K4.67%729.55K-13.00%822.62K-28.46%480.3K31.05%615.6K
Total current liabilities 3.27%406.72M20.12%482.34M1.82%418.33M-4.13%394.79M-3.94%393.83M-7.96%401.55M-3.66%410.85M-1.78%411.8M-3.77%409.99M-5.53%436.28M
Current liabilities
Long term salaries pay 32.41%30.64M32.41%30.64M32.41%30.64M32.41%30.64M--23.14M--23.14M--23.14M--23.14M--------
Deferred tax liabilities 108.91%3.16M110.61%3.38M91.05%3.31M196.40%3.46M--1.51M--1.6M--1.73M--1.17M--------
Long term deferred income -27.49%3.04M-28.02%3.26M-28.25%3.51M-26.93%3.84M-25.39%4.19M-24.05%4.54M-22.74%4.89M-21.57%5.25M-20.52%5.61M-19.56%5.97M
Lease liabilities 52.97%7.68M21.83%6.57M-46.72%3.17M9.75%3.82M54.05%5.02M148.00%5.4M171.04%5.95M48.17%3.48M-32.46%3.26M-15.29%2.18M
Total non current liabilities 31.47%44.52M26.47%43.85M13.76%40.63M26.38%41.76M281.61%33.86M325.55%34.67M318.68%35.72M265.20%33.04M-25.37%8.87M-18.47%8.15M
Total liabilities 5.51%451.24M20.62%526.2M2.78%458.96M-1.86%436.55M2.11%427.69M-1.85%436.23M2.66%446.57M3.86%444.84M-4.36%418.86M-5.80%444.43M
Shareholders equity
Paid-in capital 0.00%435.16M0.00%435.16M0.00%435.16M0.00%435.16M-0.02%435.16M-0.02%435.16M-0.17%435.16M-0.17%435.16M0.18%435.23M2.89%435.23M
Capital reserve funds 0.14%347.64M0.25%347.64M0.76%347.15M1.70%347.15M2.62%347.15M4.17%346.77M5.12%344.53M7.13%341.35M11.48%338.29M28.13%332.87M
Surplus reserve funds 27.98%77.97M27.98%77.97M27.98%77.97M27.98%77.97M55.12%60.92M55.12%60.92M55.12%60.92M55.12%60.92M25.06%39.28M25.06%39.28M
Retained profit 23.67%620.9M27.16%541.09M31.39%596.57M27.68%501.66M29.21%502.06M24.96%425.53M31.18%454.04M27.88%392.9M28.86%388.57M24.96%340.55M
Less:Treasury stock ---------5.98%22.37M-5.98%22.37M-16.78%22.37M-53.44%22.37M-54.99%23.8M-54.99%23.8M-42.00%26.89M--48.05M
Other composite income -97.21%594.07K-94.34%1M-94.79%808.07K-94.45%779.4K-33.47%21.32M-31.90%17.71M-33.18%15.5M-26.32%14.05M156.85%32.05M104.46%26M
Shareholders equity without minority interests 10.27%1.48B11.01%1.4B11.58%1.44B9.81%1.34B11.41%1.34B12.24%1.26B14.92%1.29B14.37%1.22B16.35%1.21B12.65%1.13B
Total shareholder equity 10.27%1.48B11.01%1.4B11.58%1.44B9.81%1.34B11.41%1.34B12.24%1.26B14.92%1.29B14.37%1.22B16.35%1.21B12.65%1.13B
Total liabilityies and equity 9.12%1.93B13.48%1.93B9.31%1.89B6.69%1.78B9.02%1.77B8.26%1.7B11.49%1.73B11.36%1.67B10.20%1.63B6.73%1.57B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Vitamins
Vitamins
Intraday-0.64%